NCT02818920pembrolizumabNSCLCchemotherapyP
… patients with early-stage non-small cell lung cancer (NSCLC) ( NCT02818920) evaluated the potential efficacy of pembrolizumab administrati…
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT02818920 ×
NCT02818920
This institution is selected. Its supporting articles are shown below.